Hedan tablet ameliorated non‐alcoholic steatohepatitis by moderating NF‐κB and lipid metabolism‐related pathways via regulating hepatic metabolites
Article in Journal of Cellular and Molecular Medicine (March 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids
Article in Frontiers in Pharmacology (October 2023)
MCD Diet Modulates HuR and Oxidative Stress-Related HuR Targets in Rats
Article in International Journal of Molecular Sciences (June 2023)